| Drug Name |
Tetrabenazine |
| Drug ID |
BADD_D02175 |
| Description |
A drug formerly used as an antipsychotic but now used primarily in the symptomatic treatment of various hyperkinetic disorders. It is a monoamine depletor and used as symptomatic treatment of chorea associated with Huntington's disease. FDA approved on August 15, 2008. |
| Indications and Usage |
Treatment of hyperkinetic movement disorders like chorea in Huntington's disease, hemiballismus, senile chorea, Tourette syndrome and other tic disorders, and tardive dyskinesia |
| Marketing Status |
approved; investigational |
| ATC Code |
N07XX06 |
| DrugBank ID |
DB04844
|
| KEGG ID |
D08575
|
| MeSH ID |
D013747
|
| PubChem ID |
6018
|
| TTD Drug ID |
D09PJX
|
| NDC Product Code |
51224-425; 67386-421; 68180-409; 63827-1013; 65977-0085; 47335-277; 51407-481; 27241-177; 60505-3882; 65085-0064; 27241-176; 47335-179; 69452-117; 70436-102; 43598-395; 60505-3883; 70436-101; 57821-010; 51407-480; 68682-422; 31722-821; 43598-394; 51224-426; 69452-118; 69766-076; 31722-822; 67386-422; 42973-179; 68180-408; 68682-421; 64330-066; 64567-0025; 65015-831 |
| UNII |
Z9O08YRN8O
|
| Synonyms |
Tetrabenazine | Nitoman | Xenazine |
